PHASEBIO PHARMACEUTICALS INC - COM (PHASQ)

CUSIP: 717224109

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / COM
Total 13F shares
30,813,152
Share change
+395,571
Total reported value
$95,826,492
Put/Call ratio
185%
Price per share
$3.11
Number of holders
58
Value change
+$996,233
Number of buys
34
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 717224109?
CUSIP 717224109 identifies PHASQ - PHASEBIO PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) as of Q3 2021

As of 30 Sep 2021, PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) was held by 58 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,813,152 shares. The largest 10 holders included NEA Management Company, LLC, Avidity Partners Management LP, WELLINGTON MANAGEMENT GROUP LLP, RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, Rock Springs Capital Management LP, JOHNSON & JOHNSON, Endurant Capital Management LP, Candriam Luxembourg S.C.A., and Altium Capital Management LP. This page lists 58 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.